Schedule 13G ownership disclosure

Palvella Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 697947109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 525,732.00 · Class: 4.8%

  • FHMLSP, L.P.

    Shares: 525,732.00 · Class: 4.8%

  • FHMLSP, L.L.C.

    Shares: 525,732.00 · Class: 4.8%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 155,023.00 · Class: 1.4%

  • FHMLSP Overage, L.P.

    Shares: 155,023.00 · Class: 1.4%

  • FHMLSP Overage, L.L.C.

    Shares: 155,023.00 · Class: 1.4%

  • Frazier Life Sciences X, L.P.

    Shares: 3,914.00 · Class: 0.0%

  • FHMLS X, L.P.

    Shares: 3,914.00 · Class: 0.0%

  • FHMLS X, L.L.C.

    Shares: 3,914.00 · Class: 0.0%

  • Frazier Life Sciences XI, L.P.

    Shares: 5,343.00 · Class: 0.0%

  • FHMLS XI, L.P.

    Shares: 5,343.00 · Class: 0.0%

  • FHMLS XI, L.L.C.

    Shares: 5,343.00 · Class: 0.0%

  • James N. Topper

    Shares: 690,012.00 · Class: 6.3%

  • Patrick J. Heron

    Shares: 690,012.00 · Class: 6.3%

  • Albert Cha

    Shares: 680,755.00 · Class: 6.2%

  • James Brush

    Shares: 680,755.00 · Class: 6.2%

  • Daniel Estes

    Shares: 5,343.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-012986
Form type
SCHEDULE 13G/A
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub